DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

NEWS RELEASE

Released: August 13, 2010

Department of Defense Lung Cancer Research Program
Funding for Fiscal Year 2010

The Fiscal Year 2010 (FY10) Defense Appropriations Act provides $15 million to the Department of Defense (DOD) Lung Cancer Research Program. The goal of the LCRP is to eradicate death from lung cancer to better the health and welfare of the military and the American public. For FY10 this program will support the development of an early detection program for lung cancer in military beneficiaries.

The FY10 LCRP is interested in the following clinical study areas:

  • Combination of multiple detection/screening modalities
  • Development of non-imaging-based screening program
  • Prospective validation of early detection/screening biomarkers

The FY10 LCRP will offer the Lung Cancer Early Detection Clinical Consortium Award. The Program Announcement/Funding Opportunity, including the intent of the award mechanism, eligibility, submission deadlines, and Application Instructions and General Information, are anticipated to be posted on the Grants.gov and CDMRP websites in early September 2010.

Award Mechanism Eligibility Key Mechanism Elements Funding
Lung Cancer Early Detection Clinical Consortium Award Independent investigators at or above the level of Associate Professor (or equivalent)
  • Provides support to develop the collaborations, resources, and infrastructure necessary for a consortium of institutions to execute clinical studies focused on characterizing, developing and/or improving early detection modalities for lung cancer
  • Requires collaboration with military treatment facilities to be named in the program announcement
  • The award is designed to bring together populations of high risk military beneficiaries and lung cancer patients from the specified military treatment facilities (MTFs) and the patient populations and research expertise of highly qualified civilian scientists
  • Applications shall be submitted by a lead Coordinating Center and can include an associated clinic study site (optional)
  • The maximum period of performance is 5 years
  • The maximum allowable funding for the entire period of performance is $13.5M in total costs (direct + indirect)
  • Anticipate 1 award

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to proposal submission. Proposals must be submitted through the federal government's single-entry portal, Grants.gov. Requests for email notification of the release of the Program Announcements may be sent to help@cdmrp.org. For more information about the LCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil) .

Point of Contact: